ARIEL‘s cutting edge technology integrates growing knowledgebases of genetic factors to deliver deeper insight into the complexity of a patient’s disease. ARIEL's first test, PancreasDx, aims to understand pancreatitis by evaluating 12 genes.
ARIEL understands the growing burden placed upon clinicians. We are committed to simplifying the clinical application of complex medical information.
I grew up with pancreatitis episodes from the age of two through high school. There was no diagnosis. After several upper and lower GI tests that showed nothing, it was determined it was psychological. I remember many nights being rocked by my mother and father. They must have been so confused and torn. My pain was horrible. I remember being in the hospital writhing in pain but no pain medicine given."
ARIEL Meets Your Complex Disease Needs
Most comprehensive pancreatitis genetic sequencing panel available
Secure messaging with ARIEL team on all orders
ARIEL is designed with a mobile first approach, allowing you to use ARIEL services from anywhere on any device
Track Your Order
Real time tracking keeps you up to date on all your orders
Physicians can manage their staff and colleagues right from the ARIEL Portal
Secure & Compliant
Our infrastructure is certified against the Common Security Framework (CSF) from the Health Information Trust Alliance (HITRUST) to validate our level of HIPAA compliance against the highest of industry and federal standards
ARIEL Precision Medicine is an integrated genomic and digital health company founded by Dr. David Whitcomb, one of the world’s leading visionaries in understanding and managing complex chronic diseases.